ISSN: 0270-4137

Journal Home

Journal Guideline

Prostate Q1 Unclaimed

Wiley-Liss Inc. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Prostate is a journal indexed in SJR in Oncology and Urology with an H index of 128. It has a price of 3083 €. It has an SJR impact factor of 1.059 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1.059.

Prostate focuses its scope in these topics and keywords: prostate, cancer, cell, expression, rat, human, risk, prostatic, genetic, men, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Urology (Q1) Oncology (Q2)

Price

3083 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

1.059

SJR Impact factor

128

H Index

150

Total Docs (Last Year)

460

Total Docs (3 years)

4827

Total Refs

1834

Total Cites (3 years)

453

Citable Docs (3 years)

3.81

Cites/Doc (2 years)

32.18

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Cancer Cell Q1
Journal of Clinical Oncology Q1
Annals of Oncology Q1
Molecular Cancer Q1
Cancer Discovery Q1

Compare this journals

Aims and Scope

Best articles by citations

Association of prostate cancer risk and aggressiveness to androgen pathway genes:SRD5A2,CYP17, and theAR

Effects of the lipidosterolic extract ofSerenoa repens (Permixon¬Æ) on human prostatic cell lines

Prostasomes are neuroendocrine-like vesicles in human semen

Regulation of rat prostate stromal cell myodifferentiation by androgen and TGF-?1

Genomic scan of 254 hereditary prostate cancer families

The effect of demographic and clinical factors on the relationship between BMI and PSA levels

Purification of the keratan sulfate proteoglycan expressed in prostatic secretory cells and its identification as lumican

Response to a lethal dose of heat shock by a transient up-regulation of clusterin expression followed by down-regulation and apoptosis in prostate and bladder cancer cells

Can color doppler predict the uniformity of HIFU-induced prostate tissue destruction?

Effects of transforming growth factor-?1 on parathyroid hormone-related protein mRNA expression and protein secretion in canine prostate epithelial, stromal, and carcinoma cells

Cloning, expression, and regulation by androgens of a putative member of the oxytocinase family of proteins in the rat prostate

Analysis of the inflammatory network in benign prostate hyperplasia and prostate cancer

SHOW MORE ARTICLES

Difference of cancer core distribution between first and repeat biopsy: In patients diagnosed by extensive transperineal ultrasound guided template prostate biopsy

Establishment and characterization of seven dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of prostatic cancers

Metastasis suppressor genes for prostate cancer

Prosaptide TX14A stimulates growth, migration, and invasion and activates the Raf-MEK-ERK-RSK-Elk-1 signaling pathway in prostate cancer cells

Relative and total volume of histological components in benign prostatic hyperplasia: Relationships between histological components and clinical findings

Clinical study on estramustine binding protein (EMBP) in human prostate

In situ shortening of CAG repeat length within the androgen receptor gene in prostatic cancer and its possible precursors

Imaging of bioluminescent LNCaP-luc-M6 Tumors: A new animal model for the study of metastatic human prostate cancer

Neutralizing VEGF bioactivity with a soluble chimeric VEGF-receptor protein flt(1-3)IgG inhibits testosterone-stimulated prostate growth in castrated mice

Ca2+ currents in smooth muscle cells isolated from human prostate

Anti-tumor effect of combination therapy with intratumoral controlled-release paclitaxel (PACLIMER¬Æ microspheres) and radiation

Relationship of serum sex-steroid hormones and prostate volume in African American men